ARTELO BIOSCIENCES, INC. (ARTL) Operating income 2017–2025
ARTELO BIOSCIENCES, INC. (ARTL) annual operating income history from SEC filings — each fiscal year as reported.
-$11.4MFY2025 · since FY2017: -$232,789 → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.4M | -12.8% |
| FY2024 | -$10.1M | -1.8% |
| FY2023 | -$9.9M | +3.5% |
| FY2022 | -$10.3M | -9.2% |
| FY2021 | -$9.4M | -101.0% |
| FY2020 | -$4.7M | -46.0% |
| FY2019 | -$3.2M | -37.0% |
| FY2018 | -$2.3M | -906.7% |
| FY2017 | -$232,789 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTL financial trends
ARTL RevenueARTL Net incomeARTL Net marginARTL Gross profitARTL Gross marginARTL Operating marginARTL Operating cash flowARTL Free cash flowARTL Capital expendituresARTL Return on equityARTL Stock buybacksARTL Dividends paidARTL Total assetsARTL Total liabilitiesARTL Shareholders’ equityARTL overview →